THE INTERCONVERSION OF OXO AND IMIDO LIGANDS AT A DIMOLYBDENUM CENTER - X-RAY CRYSTAL-STRUCTURE OF [(MEC5H4)MO(NPH)(MU-NPH)]2

THE INTERCONVERSION OF OXO AND IMIDO LIGANDS AT A DIMOLYBDENUM CENTER - X-RAY CRYSTAL-STRUCTURE OF [(MEC5H4)MO(NPH)(MU-NPH)]2

Bibliografski detalji
Glavni autori:	Green, M, Hogarth, G, Konidaris, P, Mountford, P
Format:	Journal article
Izdano:	1991

Slični predmeti

INTERCONVERSION OF OXO AND IMIDO LIGANDS AT A DIMOLYBDENUM CENTER - MOLECULAR AND ELECTRONIC-STRUCTURE OF [(MO(ETA-C5H4ME)(NPH)(MU-NPH))2]
od: Green, M, i dr.
Izdano: (1990)

THE INTERCONVERSION OF OXO AND IMIDO LIGANDS AT A DIMOLYBDENUM CENTER - X-RAY CRYSTAL-STRUCTURE OF [MO(ETA-C5H4ME)(NPH)(MU-NPH)]2
od: Green, M, i dr.
Izdano: (1990)

iNPH—the mystery resolving
od: Ville Leinonen, i dr.
Izdano: (2021-02-01)

Does NPH equal ischemia?
od: Messier Arthur, i dr.
Izdano: (2007-12-01)

Probable NPH in patients with clinical AD: further support for the AD-NPH syndrome and CSF circulatory failure
od: Saul T, i dr.
Izdano: (2004-12-01)

Synthesis and reactivity of the imidotungsten methyl cation [W(N2Npy)(NPh)Me]+: CO2 adds to the W=NPh bond and does not insert into the W-Me bond.
od: Ward, B, i dr.
Izdano: (2002)

Update on the Cognitive Presentations of iNPH for Clinicians
od: Tobias Langheinrich, i dr.
Izdano: (2022-07-01)

The Clinical Utility of the MOCA in iNPH Assessment
od: Eric Wesner, i dr.
Izdano: (2022-05-01)

Rational Design and Modification of NphB for Cannabinoids Biosynthesis
od: Wenhao Xia, i dr.
Izdano: (2024-09-01)

Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review
od: Efstratios-Stylianos Pyrgelis, i dr.
Izdano: (2022-11-01)

(ETA-CYCLOPENTADIENYL)IMIDO DERIVATIVES OF MOLYBDENUM AND TUNGSTEN
od: Green, M, i dr.
Izdano: (1994)

Determining the optimum time for assessing NPH patients following CSF drainage – QI study& the development of a patient satisfaction questionnaire – the Newcastle NPH questionnaire
od: M. Eltayeb, i dr.
Izdano: (2021-01-01)

New ligand platforms for developing the chemistry of the Ti=N-NR2 functional group and the insertion of alkynes into the N-N bond of a Ti=N-NPh2 ligand.
od: Selby, J, i dr.
Izdano: (2007)

Early transition metal imido and oxo complexes supported by N,N'-bis(trimethylsilyl)benzamidinate ligands
od: Stewart, P, i dr.
Izdano: (1997)

MRI imaging characteristics of brainstem and midbrain aqueduct in patients with iNPH
od: Kui Xiao, i dr.
Izdano: (2025-01-01)

Ventriculoperitoneal shunt patients and glaucoma: a cohort analysis of the NPH registry
od: Benjam Kemiläinen, i dr.
Izdano: (2024-07-01)

Ten Steps for NPH Management: Advancements in Diagnosis and Treatment of Adult Hydrocephalus
od: Alex Roman, i dr.
Izdano: (2023-09-01)

Functional modeling of the craniospinal system for in-vitro parameter studies on the pathogenesis of NPH
od: Benninghaus Anne, i dr.
Izdano: (2017-09-01)

Synthesis and crystallographic characterization of diphenylamide rare-earth metal complexes Ln(NPh2)3(THF)2 and [(Ph2N)2Ln(μ-NPh2)]2
od: Chad T. Palumbo, i dr.
Izdano: (2020-09-01)

Cycloaddition reactions of titanium and zirconium imido, oxo and hydrazido complexes supported by tetraaza macrocyclic ligands
od: Blake, A, i dr.
Izdano: (1999)

Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH)
od: Tudor, Katarina Ivana, i dr.
Izdano: (2016)

Manajemen Perioperatif Gejala Ekstrapiramidal (EPS) pada Hidrocephalus Tekanan Normal (NPH)
od: Ni Putu Dharmi Lestari, i dr.
Izdano: (2020-10-01)

Long term prognostic factors in NPH patients after ventriculo-peritoneal shunt
od: S. Colonna, i dr.
Izdano: (2022-01-01)

TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer’s disease
od: Hunter White, i dr.
Izdano: (2022-11-01)

Titanium imido complexes of cyclooctatetraenyl ligands.
od: Dunn, S, i dr.
Izdano: (2005)

A dimolybdenum complex with an alkyne ligand parallel to the metal-metal bond: synthesis, structure and cluster formation reactions of [Mo-2(mu-eta(1),eta(1)-C2Ph2)(mu-S)(mu-SPri)(2)Cp-2]
od: Adams, H, i dr.
Izdano: (2001)

ETA-CYCLOPENTADIENYL MOLYBDENUM IMIDO COMPOUNDS - HALO, ALKENE, ALKYNE, ALLYL AND TERTIARY PHOSPHINE DERIVATIVES
od: Green, M, i dr.
Izdano: (1992)

Computational Approach to Elucidating Insulin–Protamine Binding Interactions and Dynamics in Insulin NPH Formulations
od: Ketan Kumar Rohilla, i dr.
Izdano: (2024-01-01)

Clinical Outcomes After Ventriculo-Peritoneal Shunting in Patients With Classic vs. Complex NPH
od: Eng Tah Goh, i dr.
Izdano: (2022-07-01)

BIS(ETA-CYCLOPENTADIENYL)-MOLYBDENUM AND -TUNGSTEN IMIDO COMPLEXES - X-RAY STRUCTURES OF [MO(ETA-C5H5)2(NBU(T))] AND [MO(ETA-C5H4ME)2(NBU(T))ME]I
od: Green, J, i dr.
Izdano: (1992)

Normal pressure hydrocephalus (NPH) is a brain disorder that normally occurs in older adults. It deteriorates functional status and quality of life, particularly ambulation, micturation control, and cognitive ability. NPH patients for which there is no id
od: Jantana Klaycharoen
Izdano: (2016-06-01)

Group IV imido complexes supported by azamacrocyclic ligands
od: Swallow, D, i dr.
Izdano: (1996)

Titanium imido complexes with tetraaza macrocyclic ligands
od: Swallow, D, i dr.
Izdano: (1998)

New titanium imido chemistry with polydentate N-donor ligands
od: Mountford, P
Izdano: (2003)

A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus (iNPH).
od: Tommaso eSchirinzi, i dr.
Izdano: (2015-04-01)

All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine.
od: Arto Y Strandberg, i dr.
Izdano: (2016-01-01)

Incidental findings of typical iNPH imaging signs in asymptomatic subjects with subclinical cognitive decline
od: Doortje C. Engel, i dr.
Izdano: (2021-08-01)

Synthesis and reactions of group 4 imido complexes supported by cyclooctatetraene ligands
od: Dunn, S, i dr.
Izdano: (2006)

New transition metal imido chemistry with diamido-donor ligands
od: Gade, L, i dr.
Izdano: (2001)

Group 4 imido complexes supported by azamacrocyclic ligands
od: Swallow, D, i dr.
Izdano: (1996)